blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3809878

EP3809878 - COMPOSITION COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN IMPROVING, ENHANCING, PROMOTING OR MODULATING A SEROTONERGIC FUNCTION IN THE CENTRAL NERVOUS SYSTEM [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  10.03.2023
Database last updated on 18.05.2024
FormerRequest for examination was made
Status updated on  26.03.2021
FormerThe international publication has been made
Status updated on  03.01.2020
Formerunknown
Status updated on  08.07.2019
Most recent event   Tooltip13.04.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Société des Produits Nestlé S.A.
Entre-deux-Villes
1800 Vevey / CH
[2024/18]
Former [2021/17]For all designated states
Société des Produits Nestlé S.A.
Entre-deux-Villes
1800 Vevey / CH
Inventor(s)01 / HAUSER, Jonas
39, Rue de l'Ale
1003 LAUSANNE / CH
02 / YAN, Jian
501 Roy Street
Unit T305
Seattle, WA 98109 / US
 [2023/32]
Former [2021/17]01 / HAUSER, Jonas
39, Rue de l'Ale
1003 LAUSANNE / CH
02 / YAN, Jian
Av. de Corsier 10
1800 VEVEY / CH
Representative(s)Krishnan, Sri
Société des Produits Nestlé S.A.
Avenue Nestlé 55
1800 Vevey / CH
[2021/17]
Application number, filing date19733948.421.05.2019
[2021/17]
WO2019EP63029
Priority number, dateUS201862689293P25.06.2018         Original published format: US 201862689293 P
[2021/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020001862
Date:02.01.2020
Language:EN
[2020/01]
Type: A1 Application with search report 
No.:EP3809878
Date:28.04.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 02.01.2020 takes the place of the publication of the European patent application.
[2021/17]
Search report(s)International search report - published on:EP02.01.2020
ClassificationIPC:A23L33/10, A23L33/21, A23L33/00, A61K31/702
[2021/17]
CPC:
A23L33/21 (EP,US); A23L33/40 (EP,US); A23L33/10 (EP,US);
A61K31/702 (EP,US); A61K45/06 (EP); A23V2002/00 (EP);
A23V2200/3202 (EP); A23V2200/322 (EP); A23V2250/28 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/17]
TitleGerman:ZUSAMMENSETZUNG MIT MENSCHLICHEN MILCHOLIGOSACCHARIDEN ZUR VERWENDUNG BEI DER VERBESSERUNG, VERSTÄRKUNG, FÖRDERUNG ODER MODULATION EINER SEROTONERGEN FUNKTION IM ZENTRALNERVENSYSTEM[2021/17]
English:COMPOSITION COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN IMPROVING, ENHANCING, PROMOTING OR MODULATING A SEROTONERGIC FUNCTION IN THE CENTRAL NERVOUS SYSTEM[2021/17]
French:COMPOSITION COMPRENANT DES OLIGOSACCHARIDES DE LAIT HUMAIN DESTINÉE À ÊTRE UTILISÉE DANS L'AMÉLIORATION, LE PERFECTIONNEMENT, LA PROMOTION OU LA MODULATION D'UNE FONCTION SÉROTONINERGIQUE DANS LE SYSTÈME NERVEUX CENTRAL[2021/17]
Entry into regional phase25.01.2021National basic fee paid 
25.01.2021Designation fee(s) paid 
25.01.2021Examination fee paid 
Examination procedure20.01.2021Amendment by applicant (claims and/or description)
25.01.2021Examination requested  [2021/17]
25.01.2021Date on which the examining division has become responsible
14.03.2023Despatch of a communication from the examining division (Time limit: M06)
15.09.2023Reply to a communication from the examining division
Fees paidRenewal fee
13.05.2021Renewal fee patent year 03
14.03.2022Renewal fee patent year 04
14.03.2023Renewal fee patent year 05
12.04.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XAI]WO2015086789  (NESTEC SA [CH]) [X] 1-4,7,9,11-13,15,16 * page 25, line 7 - line 12; claims 1-3, 14, 15 * [A] 14 [I] 5,6,8,10;
 [A]US2015231213  (CHICHLOWSKI MACIEJ [US], et al) [A] 1-16* the whole document *;
 [XAI]WO2016066735  (NESTEC SA [CH]) [X] 1,4,6,9,11-13 * claim 1 * [A] 14-16 [I] 2,3,5,7,8,10;
 [XAI]WO2016146789  (NESTEC SA [CH]) [X] 1,4,7,9,11-13 * page 1, line 6 - line 11; claims 1, 15 * [A] 14-16 [I] 2,3,5,6,8,10;
 [XAI]US2018103675  (CHICHLOWSKI MACIEJ [US], et al) [X] 1,4,5,7-9,11-13 * paragraph [0124]; claims 1, 6, 7 * [A] 14-16 [I] 2,3,6,10
by applicantUS5288637
 WO9610086
 EP0975235
    - HUANG, E.J.REICHARDT, L. F., "Neurotrophins: Roles in Neuronal Development and Function", Annu. Rev. Neurosci., (20010000), vol. 24, pages 677 - 736
    - MUSUMECI, G.MINICHIELLO, L., "BDNF-TrkB signalling in fear learning: from genetics to neural networks", Rev. Neurosci., (20110000), vol. 22, no. 3, pages 303 - 15
    - XIAO, J. et al., "The role of neurotrophins in the regulation of myelin development", Neurosignals, (20090000), vol. 17, pages 265 - 276
    - VON BOHLENHALBACH, O., "Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus", Cell Tissue Res., (20110000), vol. 345, no. 1, pages 1 - 19, XP019923388

DOI:   http://dx.doi.org/10.1007/s00441-011-1196-4
    - LUBSEN, J. et al., "Microstructural and functional connectivity in the developing preterm brain", Seminars in Perinatology, (20110000), vol. 35, pages 34 - 43
    - TALGE, N. et al., "Late-Preterm Birth and its Association with Cognitive and Socioemotional Outcomes at 6 Years of Age", Pediatrics, (20100000), vol. 126, pages 1124 - 1131
    - VAN BAAR, A. et al., "Functioning at school age of moderately preterm children born at 32 to 36 weeks' gestational age", Pediatrics, (20090000), vol. 124, pages 251 - 257
    - FAROOQI, A et al., "Impact at age 11 years of major neonatal morbidities in children born extremely preterm", Pediatrics, (20110000), vol. 127, pages e1247 - 1257
    - ALLEN, M.C., "Neurodevelopmental outcomes of preterm infants", Curr. Opin Neurol., (20080000), vol. 21, no. 2, pages 123 - 8
    - GREGORY, A. et al., "Intrauterine Growth Restriction Affects the Preterm Infant's Hippocampus", Pediatric Research, (20080000), vol. 63, no. 4, pages 438 - 443
    - BARRETT, R. D. et al., "Destruction and reconstruction: hypoxia and the developing brain", Birth Defects Res. C. Embryo Today, (20070000), vol. 81, pages 163 - 76
    - ROZE et al., "The apparent breastfeeding paradox in very preterm infants: relationship between breast feeding, early weight gain and neurodevelopment based on results from two cohorts, EPIPAGE and LIFT", BMJ Open, (20120000), vol. 2, page e000834
    - HUPPI, P.S., "Nutrition for the Brain", Pediatric Research, (20080000), vol. 63, no. 3, pages 229 - 231
    - CUSIKGEORGIEFF, "The Role of Nutrition in Brain Development: The Golden Opportunity of the ''First 1000 Days", Journal of Pediatrics, (20160000), vol. 175, pages 16 - 21, XP029659252

DOI:   http://dx.doi.org/10.1016/j.jpeds.2016.05.013
    - HORTON, R, The Lancet, (20080000), vol. 371, no. 9608, page 179
    - LAUS, M.F. et al., "Early postnatal protein-calorie malnutrition and cognition: a review of human and animal studies", Int. J. Environ. Res. Public Health., (20110000), vol. 8, no. 2, pages 590 - 612
    - MERENS et al., Journal of Affective Disorders, (20070000), vol. 103, pages 43 - 62
    - GIBSON GRROBERFROID MB, "Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics", J Nutr., (19950000), vol. 125, pages 1401 - 12
    - SALMINEN SOUWEHAND A.BENNO Y. et al., "Probiotics: how should they be defined", Trends Food Sci. Technol., (19990000), vol. 10, pages 107 - 10, XP055150446
    - WRODNIGG, T.M.STUTZ, A.E., Angew. Chem. Int. Ed., (19990000), vol. 38, pages 827 - 828
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.